|
PPP3R1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.982100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.096800E-03 |
| Normal-vs-Stage2 |
2.037800E-01 |
| Normal-vs-Stage3 |
3.669000E-01 |
| Normal-vs-Stage4 |
7.298400E-01 |
| Stage1-vs-Stage2 |
8.198800E-01 |
| Stage1-vs-Stage3 |
5.821700E-02 |
| Stage1-vs-Stage4 |
2.784400E-02 |
| Stage2-vs-Stage3 |
4.586000E-01 |
| Stage2-vs-Stage4 |
3.083600E-01 |
| Stage3-vs-Stage4 |
6.301200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.186010E-02 |
| Normal-vs-AfricanAmerican |
3.176800E-01 |
| Normal-vs-Asian |
2.892000E-01 |
| Caucasian-vs-AfricanAmerican |
6.963700E-04 |
| Caucasian-vs-Asian |
9.093400E-01 |
| AfricanAmerican-vs-Asian |
1.351030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.082000E-02 |
| Normal-vs-Female |
1.621960E-02 |
| Male-vs-Female |
2.792800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.715600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.019800E-02 |
| Normal-vs-Age(61-80Yrs) |
9.514400E-02 |
| Normal-vs-Age(81-100Yrs) |
9.663400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.472400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.283400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.391000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.239000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.853000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.403000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.875730E-02 |
| Normal-vs-Grade 2 |
9.350200E-04 |
| Normal-vs-Grade 3 |
5.121200E-01 |
| Normal-vs-Grade 4 |
5.769000E-01 |
| Grade 1-vs-Grade 2 |
6.917200E-01 |
| Grade 1-vs-Grade 3 |
4.198400E-02 |
| Grade 1-vs-Grade 4 |
1.004810E-01 |
| Grade 2-vs-Grade 3 |
7.448700E-04 |
| Grade 2-vs-Grade 4 |
1.852270E-02 |
| Grade 3-vs-Grade 4 |
9.495600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.35009999999258E-05 |
| Normal-vs-ccB subtype |
3.050600E-01 |
| ccA subtype-vs-ccB subtype |
4.170400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.465800E-02 |
| Normal-vs-N1 |
8.083600E-01 |
| N0-vs-N1 |
4.151000E-01 |
|
|
